Skip to main content
logo
IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.0021
+0.0010 (90.91%)
At close: Jul 24, 2026

IR-Med Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-1.46-1.94-4.91-4.76-3.68-0.73
Net Income
-2.35-1.9-4.91-4.73-3.72-0.75
Earnings Per Share
-0.03-0.03-0.07-0.07-0.06-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.060.130.7732.821.87
Total Debt
0.250.160.20.280.180.17
Net Cash (Debt)
-0.19-0.030.572.732.641.7
Net Cash Growth
---79.20%3.34%55.18%1831.82%
Net Cash Per Share
-0.00-0.000.010.040.040.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-0.84-1.39-3.23-3.38-2.48-0.4
Capital Expenditures
---0-0.05-0.03-
Free Cash Flow
-0.84-1.39-3.23-3.43-2.51-0.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------
Operating Margin
------
Profit Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
------